Back to search
FDAFDA · Food and drugs·Recall number D-1027-2019

2% Lidocaine HCl Injectable Solution, 100 mg/5 mL (20 mg per mL), 5mL Sterile single use syringe, NDC: 42852-011-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404

Published March 27, 2019 · Recall initiated: March 13, 2019

Summary

FDA records drug Class II recall D-1027-2019, published March 27, 2019 and initiated March 13, 2019. Recalling firm: Advanced Pharma Inc.; Status: Terminated; Reported quantity: 1980 syringes; Lot: Lot: 10/19/18 1990 01167S Exp. 3/18/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Advanced Pharma Inc.
Distributor
Nationwide
Lot
Lot: 10/19/18 1990 01167S Exp. 3/18/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 2% Lidocaine HCl Injectable Solution, 100 mg/5 mL (20 mg per mL), 5mL Sterile single use syringe, NDC: 42852-011-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404 recalled?

Yes. FDA published recall D-1027-2019 on March 27, 2019. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter